Abstract
The emergence of multidrug resistant microorganisms together with the decline in discovery and development of new antibiotics is of great concern in health-care policy. In this alarming context, an early and well-tailored antibiotic therapy is a relevant strategy not only to improve clinical outcome but also to avoid appearance and spreading of perilous resistant strains. One of the most common antibiotic classes is fluoroquinolones. They trap the DNA girase and/or topoisomerase IV on the DNA, resulting in DNA fragmentation. We have developed the Micromax® assay to determine, in situ, the integrity of the chromosomal DNA-nucleoid from microorganisms. This was validated as a simple procedure for the rapid assessment of the susceptibility or resistance to quinolones in gram-negative bacteria. After incubating with the quinolone, cells are trapped in an agarose microgel on a slide and incubated with a specific lysing solution to remove the cell wall and visualize the nucleoids under fluorescence microscopy. If the strain is susceptible to the quinolone, the bacterial nucleoids show a halo of diffusing DNA spots of fragmented DNA, whereas they appear intact in the resistant strain. The technical processing is performed in 40 min with practically total sensitivity and specificity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (2014) Antimicrobial resistance: global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed 25 Mar 2015.
Peleg AY, Hooper DC (2010) Hospital-acquired infections due to gram negative bacteria. N Engl J Med 362:1804–1813
Jorgensen JH, Ferraro MJ (2009) Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis 49:1749–1755
Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262–268
Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH (2008) Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic resistant gram-negative bacteria. Chest 134:281–287
Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P (2006) Comparison of mortality of patients with Acinetobacter Baumannii bacteriemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 57:1251–1254
Falagas ME, Bliziotis IA (2007) Pandrug-resistant gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29:630–636
Drlica K, Malik M, Kerns RJ, Zhao X (2008) Quinolone-mediated bacterial death. Antimicrob Agents Chemother 52:385–392
Malik M, Zhao X, Drlica K (2006) Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol Microbiol 61:810–825
Chen F-J, Lo H-J (2003) Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect 36:1–9
Martínez-Martínez L, Pascual A, Jacoby GA (1998) Quinolone resistance from a transferable plasmid. Lancet 351:797–799
Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12:83–88
Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51:1109–1117
Fernández JL, Cartelle M, Muriel L, Santiso R, Tamayo M, Goyanes V, Gosálvez J, Bou G (2008) DNA fragmentation in microorganisms assessed in situ. Appl Environ Microbiol 74:5925–5933
Tamayo M, Santiso R, Gosalvez J, Bou G, Fernández JL (2009) Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC Microbiol 13:9–69
Santiso R, Tamayo M, Fernández JL, del Carmen Fernández M, Molina F, Villanueva R, Gosálvez J, Bou G (2009) Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coli. J Clin Microbiol 47:2593–2595
Bou G, Otero FM, Santiso R, Tamayo M, Fernández Mdel C, Tomás M, Gosálvez J, Fernández JL (2012) Fast assessment of resistance to carbapenems and ciprofloxacin of clinical strains of Acinetobacter Baumannii. J Clin Microbiol 50:3609–3613
Clinical and Laboratory Standards Institute (2014) Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement M100-S24, vol 34, 1st edn. Clinical and Laboratory Standards Institute, Wayne, PA
Acknowledgments
This work was supported by Fondo de Investigaciones Sanitarias (FIS PI14/01346).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Otero, F., Santiso, R., Tamayo, M., Bou, G., Gosálvez, J., Fernández, J.L. (2017). Rapid Detection of Bacterial Susceptibility or Resistance to Quinolones. In: Didenko, V. (eds) Fast Detection of DNA Damage. Methods in Molecular Biology, vol 1644. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7187-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7187-9_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7185-5
Online ISBN: 978-1-4939-7187-9
eBook Packages: Springer Protocols